167 related articles for article (PubMed ID: 30357330)
1. Bacterial inclusion bodies are industrially exploitable amyloids.
de Marco A; Ferrer-Miralles N; Garcia-Fruitós E; Mitraki A; Peternel S; Rinas U; Trujillo-Roldán MA; Valdez-Cruz NA; Vázquez E; Villaverde A
FEMS Microbiol Rev; 2019 Jan; 43(1):53-72. PubMed ID: 30357330
[TBL] [Abstract][Full Text] [Related]
2. Bacterial Inclusion Bodies: Discovering Their Better Half.
Rinas U; Garcia-Fruitós E; Corchero JL; Vázquez E; Seras-Franzoso J; Villaverde A
Trends Biochem Sci; 2017 Sep; 42(9):726-737. PubMed ID: 28254353
[TBL] [Abstract][Full Text] [Related]
3. Supramolecular organization of protein-releasing functional amyloids solved in bacterial inclusion bodies.
Cano-Garrido O; Rodríguez-Carmona E; Díez-Gil C; Vázquez E; Elizondo E; Cubarsi R; Seras-Franzoso J; Corchero JL; Rinas U; Ratera I; Ventosa N; Veciana J; Villaverde A; García-Fruitós E
Acta Biomater; 2013 Apr; 9(4):6134-42. PubMed ID: 23220450
[TBL] [Abstract][Full Text] [Related]
4. Bacterial inclusion bodies: making gold from waste.
García-Fruitós E; Vázquez E; Díez-Gil C; Corchero JL; Seras-Franzoso J; Ratera I; Veciana J; Villaverde A
Trends Biotechnol; 2012 Feb; 30(2):65-70. PubMed ID: 22037492
[TBL] [Abstract][Full Text] [Related]
5. Bacterial mimetics of endocrine secretory granules as immobilized in vivo depots for functional protein drugs.
Céspedes MV; Fernández Y; Unzueta U; Mendoza R; Seras-Franzoso J; Sánchez-Chardi A; Álamo P; Toledo-Rubio V; Ferrer-Miralles N; Vázquez E; Schwartz S; Abasolo I; Corchero JL; Mangues R; Villaverde A
Sci Rep; 2016 Oct; 6():35765. PubMed ID: 27775083
[TBL] [Abstract][Full Text] [Related]
6. Engineering Secretory Amyloids for Remote and Highly Selective Destruction of Metastatic Foci.
Céspedes MV; Cano-Garrido O; Álamo P; Sala R; Gallardo A; Serna N; Falgàs A; Voltà-Durán E; Casanova I; Sánchez-Chardi A; López-Laguna H; Sánchez-García L; Sánchez JM; Unzueta U; Vázquez E; Mangues R; Villaverde A
Adv Mater; 2020 Feb; 32(7):e1907348. PubMed ID: 31879981
[TBL] [Abstract][Full Text] [Related]
7. Studies on bacterial inclusion bodies.
de Groot NS; Espargaró A; Morell M; Ventura S
Future Microbiol; 2008 Aug; 3(4):423-35. PubMed ID: 18651814
[TBL] [Abstract][Full Text] [Related]
8. Isolation of cell-free bacterial inclusion bodies.
Rodríguez-Carmona E; Cano-Garrido O; Seras-Franzoso J; Villaverde A; García-Fruitós E
Microb Cell Fact; 2010 Sep; 9():71. PubMed ID: 20849629
[TBL] [Abstract][Full Text] [Related]
9. Amyloids in bacterial inclusion bodies.
de Groot NS; Sabate R; Ventura S
Trends Biochem Sci; 2009 Aug; 34(8):408-16. PubMed ID: 19647433
[TBL] [Abstract][Full Text] [Related]
10. Protein activity in bacterial inclusion bodies correlates with predicted aggregation rates.
de Groot NS; Ventura S
J Biotechnol; 2006 Aug; 125(1):110-3. PubMed ID: 16621081
[TBL] [Abstract][Full Text] [Related]
11. Biological role of bacterial inclusion bodies: a model for amyloid aggregation.
García-Fruitós E; Sabate R; de Groot NS; Villaverde A; Ventura S
FEBS J; 2011 Jul; 278(14):2419-27. PubMed ID: 21569209
[TBL] [Abstract][Full Text] [Related]
12. Catalytically-active inclusion bodies-Carrier-free protein immobilizates for application in biotechnology and biomedicine.
Krauss U; Jäger VD; Diener M; Pohl M; Jaeger KE
J Biotechnol; 2017 Sep; 258():136-147. PubMed ID: 28465211
[TBL] [Abstract][Full Text] [Related]
13. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
[TBL] [Abstract][Full Text] [Related]
14. Amyloid-like properties of bacterial inclusion bodies.
Carrió M; González-Montalbán N; Vera A; Villaverde A; Ventura S
J Mol Biol; 2005 Apr; 347(5):1025-37. PubMed ID: 15784261
[TBL] [Abstract][Full Text] [Related]
15. Engineering tumor cell targeting in nanoscale amyloidal materials.
Unzueta U; Seras-Franzoso J; Céspedes MV; Saccardo P; Cortés F; Rueda F; Garcia-Fruitós E; Ferrer-Miralles N; Mangues R; Vázquez E; Villaverde A
Nanotechnology; 2017 Jan; 28(1):015102. PubMed ID: 27893441
[TBL] [Abstract][Full Text] [Related]
16. Bacterial Inclusion Bodies for Anti-Amyloid Drug Discovery: Current and Future Screening Methods.
Caballero AB; Espargaró A; Pont C; Busquets MA; Estelrich J; Muñoz-Torrero D; Gamez P; Sabate R
Curr Protein Pept Sci; 2019; 20(6):563-576. PubMed ID: 30924417
[TBL] [Abstract][Full Text] [Related]
17. In situ protein folding and activation in bacterial inclusion bodies.
Gonzalez-Montalban N; Natalello A; García-Fruitós E; Villaverde A; Doglia SM
Biotechnol Bioeng; 2008 Jul; 100(4):797-802. PubMed ID: 18351678
[TBL] [Abstract][Full Text] [Related]
18. Concepts and tools to exploit the potential of bacterial inclusion bodies in protein science and biotechnology.
Gatti-Lafranconi P; Natalello A; Ami D; Doglia SM; Lotti M
FEBS J; 2011 Jul; 278(14):2408-18. PubMed ID: 21569207
[TBL] [Abstract][Full Text] [Related]
19. Protein aggregation in recombinant bacteria: biological role of inclusion bodies.
Villaverde A; Carrió MM
Biotechnol Lett; 2003 Sep; 25(17):1385-95. PubMed ID: 14514038
[TBL] [Abstract][Full Text] [Related]
20. Inclusion body anatomy and functioning of chaperone-mediated in vivo inclusion body disassembly during high-level recombinant protein production in Escherichia coli.
Rinas U; Hoffmann F; Betiku E; Estapé D; Marten S
J Biotechnol; 2007 Jan; 127(2):244-57. PubMed ID: 16945443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
